EFFECTS OF SGLT-2 INHIBITORS ON 24 H AMBP IN PATIENTS WITH TYPE 2 DIABETIC AND HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Wang, Qiongying [1 ]
Tian, Li [1 ]
Yu, Jing [1 ]
Bai, Feng [1 ]
机构：
[1] Lanzhou Univ Second Hosp, Lanzhou, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PS-C30-11
引用
收藏
页码：E466 / E466
页数：1
相关论文
共 50 条
  • [41] Effects of SGLT2 inhibitors on the cardiovascular outcomes in patients with cancer: a systematic review and meta-analysis
    Liu, L.
    Chen, H. H.
    Kuo, H. H.
    Lin, P. L.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus
    Tsapas, A.
    Vassilakou, D.
    Athanasiadou, E.
    Karagiannis, T.
    Matthews, D. R.
    DIABETOLOGIA, 2012, 55 : S107 - S107
  • [43] SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
    Neuen, Brendan L.
    Young, Tamara
    Heerspink, Hiddo J. L.
    Neal, Bruce
    Perkovic, Vlado
    Billot, Laurent
    Mahaffey, Kenneth W.
    Charytan, David M.
    Wheeler, David C.
    Arnott, Clare
    Bornpoint, Severine
    Levin, Adeera
    Jardine, Meg J.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (11): : 845 - 854
  • [44] SGLT2 Inhibitors and Stroke Risk in Patients with Type 2 Diabetes-A Systematic Review and Meta-analysis
    Guo, Man
    Xu, Yong
    DIABETES, 2018, 67
  • [45] Heart failure hospitalization with SGLT-2 inhibitors: a systematic review and meta-analysis of randomized controlled and observational studies
    Singh, Awadhesh Kumar
    Singh, Ritu
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (04) : 299 - 308
  • [46] Incretin based therapies and SGLT-2 inhibitors in kidney transplant recipients with diabetes: A systematic review and meta-analysis
    Oikonomaki, Dora
    Dounousi, Evangelia
    Duni, Anila
    Roumeliotis, Stefanos
    Liakopoulos, Vassilios
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 172
  • [47] Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials
    Giugliano, Dario
    Longo, Miriam
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Chiodini, Paolo
    Solerte, Sebastiano Bruno
    Esposito, Katherine
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [48] SIDE EFFECTS OF SGLT-2 INHIBITORS IN PATIENTS WITH HEART FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Pozzi, A.
    Cirelli, C.
    Merlo, A.
    Scangiuzzi, C.
    Rea, F.
    Tavano, E.
    Iorio, A.
    Giovanni, C.
    Senni, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [49] Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
    Yang, Shiwen
    Liu, Ying
    Zhang, Shengzhao
    Wu, Fengbo
    Liu, Dan
    Wu, Qingfang
    Zheng, Hanrui
    Fan, Ping
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [50] Description of the utilization patterns of SGLT-2 inhibitors in type 2 diabetic patients in Korea
    Kim, Hyeonjeong
    Seo, Ayeong
    Kim, Bong Gi
    Kim, Eun Jin
    Noh, Eunsun
    Chung, Soo Youn
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 160 - 160
12345